Joseph J. Vallner
Keine laufenden Positionen mehr
Profil
Joseph J.
Vallner served as President and Chief Operating Officer at Cell Genesys, Inc. from 1999 to 2006.
He was also President and Chief Executive Officer at Soleno Therapeutics, Inc. from 2006 to 2007, and President and Interim Chief Executive Officer at Lumera Corp.
from 2006 to 2008.
Vallner was a Director at GigPeak, Inc. from 2008 to 2010 and a Director at California Healthcare Institute.
He also served as President at Viropro, Inc. from 2015 to 2016.
Vallner received his undergraduate, graduate, and doctorate degrees from the University of Wisconsin.
Ehemalige bekannte Positionen von Joseph J. Vallner
| Unternehmen | Position | Ende |
|---|---|---|
| VIROPRO INC. | Vorstandsvorsitzender | - |
| GIGPEAK INC | Direktor/Vorstandsmitglied | 07.06.2010 |
Lumera Corp.
 Lumera Corp. Packaged SoftwareTechnology Services Lumera Corp. develops proprietary polymer materials and products for a broad range of applications. The company designs proprietary molecular structures and polymer compounds for a broad range of electro-optic, bioscience, RF and specialty nanotechnology applications. The company also has developed proprietary processes for fabricating such devices. Lumera Corp. is headquartered in Bothell, WA. | Präsident | 11.12.2008 |
| SOLENO THERAPEUTICS, INC. | Präsident | 01.07.2007 |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Präsident | 31.10.2006 |
Ausbildung von Joseph J. Vallner
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| VIROPRO INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Lumera Corp.
Lumera Corp. Packaged SoftwareTechnology Services Lumera Corp. develops proprietary polymer materials and products for a broad range of applications. The company designs proprietary molecular structures and polymer compounds for a broad range of electro-optic, bioscience, RF and specialty nanotechnology applications. The company also has developed proprietary processes for fabricating such devices. Lumera Corp. is headquartered in Bothell, WA. | Technology Services |
| California Healthcare Institute | Health Technology |
GigPeak, Inc.
 GigPeak, Inc. SemiconductorsElectronic Technology GigPeak, Inc. supplied semiconductor and electro-optical component products. Its products include telecom, distribution, contribution and datacom wireless and RF MMICs. The company was founded by Avishay S. Katz and Andrea Betti-Berutto in March 2008 and was headquartered in San Jose, CA. | Electronic Technology |